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Abstract 
Prenatal development and growth are critical to survival of the fetus and neonate. 
Recent evidence suggests that a critical period for determining growth is the 
pre-implantation period of pregnancy during which differentiation, organogenesis and 
development of the embryo occur and the embryo is considerably vulnerable to uterine 
environmental factors. The objectives of the present study were to examine the effects of 
restrictive uterine environments on embryo development using two sheep models of 
maternal constraint: litter size and dam size, and to identify embryonic and 
maternally-driven mechanisms that regulate development of the peri-implantation sheep 
embryo. 
Morphometric analysis (embryo length, width and heart bulge width) of the embryos in 
peri-implantation single and twin embryos was inconclusive; as was the transcriptomics 
analysis of whole embryos using RNA-seq to examine differential gene expression that may 
be responsible for differential regulation of growth.  
In a dam size model, large-breed Suffolk embryos gestated in small-breed Cheviot ewes 
(constrained environment) were smaller than Suffolk embryos gestated in Suffolk ewes 
(control) at day 19 of pregnancy, confirming previous findings that maternal constraint is 
evident in early pregnancy when limitations of space are not of consequence. Progesterone 
administered in the post-ovulatory period, day 0 to 6, alleviates this apparent constraint 
such that Suffolk embryos gestated in Cheviot ewes that received progesterone are larger 
than those gestated in Cheviot ewes that did not. Further, differential gene expression 
analysis of maternal uterine tissues showed that at day 6 and day 19 endometrial genes that 
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encode for histotroph secretion and uterine receptivity are altered by post-ovulatory 
progesterone administration. Timing of administration of progesterone is critical not only to 
embryo growth but also to embryo survival. There were lower pregnancy rates in the ewes 
that received progesterone from day 0 than those that received progesterone from day 2. 
The results of this thesis indicate that progesterone exerts its effects by regulation of 
genes that encode for uterine structural and secretory activity to advance the uterus. This 
likely forces the asynchronous embryo to accelerate its growth in order to adapt to its 
environment. These findings contribute to the knowledge of the regulatory mechanisms 
controlling early embryo growth and present a platform within the livestock industry and 
human reproductive technology practice to manipulate embryo growth to improve survival 
of offspring. 
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